Clinical Trial Update: A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis [Phase 3]

View source ↗

Summary

This clinical trial update announces the completion of a Phase 3 study evaluating deferasirox for long-term treatment in patients with beta-thalassemia and tran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Transfusional Iron Overload

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

Sponsor: Novartis | Conditions: Beta-Thalassemia, Hemosiderosis | Phase 3 | Status: COMPLETED